BillionToOne, Inc. reported $397M of revenue over the trailing twelve months. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $397M (to Q2 2026). Net income: $38M, trailing twelve months to Q2 2026. Free cash flow: $33M, trailing twelve months to Q2 2026. Operating margin: 11%, trailing twelve months to Q2 2026.

BLLNBillionToOne, Inc.

Healthcare

$98.15

$64.0352 weeks$149.76

BLLN as reported

BillionToOne, Inc. reported $397M of revenue over the trailing twelve months. 10 reported series are charted on this page, each one as filed.

$397M

Revenue, trailing twelve months · to Q2 2026 · every figure below is as filed, with no scoring applied

Net income: $38M
Net income · trailing twelve months to Q2 2026
Free cash flow: $33M
Free cash flow · trailing twelve months to Q2 2026
Operating margin: 11%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for BLLN, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$397M	n/a	Q2 2026
Net income	$38M	n/a	Q2 2026
EPS	$0.70	n/a	Q2 2026
Gross margin	71%	n/a	Q2 2026
Operating margin	11%	n/a	Q2 2026
Net margin	9.2%	n/a	Q2 2026
ROE	4.6%	n/a	Q2 2026
ROA	1.9%	n/a	Q2 2026
ROIC	31%	n/a	Q2 2026
Free cash flow	$33M	n/a	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.